In order to maintain control of T2DM, all subjects were taking glucose-lowering medications, as
prescribed by their physician, including metmorfin (n = 26) and insulin (n = 6). In addition, 18 subjects
were taking blood pressure medication and 9 were on reductase inhibitors.